# Chongqing Daxin Pharmaceutical Co., Ltd. – FDA Inspection, Apr 18, 2013

Source: https://www.keypedia.com/records/fda_inspections/chongqing-daxin-pharmaceutical-co-ltd/31798eea-e595-4356-9da9-977f526ea7a7
Source feed: FDA_Inspections

> FDA inspection 829548 of Chongqing Daxin Pharmaceutical Co., Ltd., April 18, 2013. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 829548
- Company Name: Chongqing Daxin Pharmaceutical Co., Ltd.
- Inspection Date: 2013-04-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 984549 - 2016-08-04
- FDA Inspection 616428 - 2009-08-06

Company: https://www.keypedia.com/companies/chongqing-daxin-pharmaceutical-co-ltd/2d98394c-de0a-498c-bb6a-9a3a97f813eb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c